KaloBios Provides Update on Pipeline of Clinical Programs PipelineReview.com (press release) SOUTH SAN FRANCISCO, CA, USA I June 27, 2013 I PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on the status of its ongoing clinical programs for KB003, KB001-A and KB004, its pipeline of proprietary ... |
